文献速递泌尿生殖介入PETCTMR

雄激素剥夺治疗对18F胆碱PET/CT识别的前列腺内肿瘤体积的影响:用于前列腺剂量绘画放疗

Effect of androgen deprivation therapy on intraprostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.
PubMed 文献 · Br J Radiol · 2016-12-20

本研究评估雄激素剥夺治疗(ADT)对18F胆碱PET/CT识别前列腺内优势病灶(DIL)及推量体积的影响。结果显示ADT使前列腺总体积缩小17%,视觉法PET DIL显著小于对应mpMRI DIL(p=0.03),且3例无视觉可识别PET DIL;所有ADT前扫描患者均有至少一个视觉可识别PET DIL且与MRI大小无显著差异。作者认为视觉勾画推量体积应在ADT前进行18F胆碱PET/CT,阈值勾画时高于60%前列腺SUVmax的阈值可能更合适。

要点

  • ADT使前列腺体积缩小17%,视觉法PET DIL显著小于mpMRI DIL(p=0.03)。
  • ADT期间3例无视觉可识别PET DIL,ADT前扫描者均有至少一个视觉可识别PET DIL。
  • 阈值法PET产生的DIL均大于视觉法PET,两种PET方法对MRI定义病灶敏感度中等(0.50-0.68)、特异度高(0.85-0.98)。

核心结论

  • 对于前列腺剂量绘画放疗中视觉勾画推量体积,18F胆碱PET/CT应在ADT前进行;对于采用本研究PET/CT扫描方案的阈值勾画,高于60%前列腺SUVmax的阈值可能更合适;PET联合MRI较单用MRI可显著改变总体推量体积。

研究设计与样本

  • 研究比较ADT期间与ADT前两种扫描时机的前列腺癌患者,PET/CT在ADT期间进行者11例(中位持续时间85天),ADT前进行者29例,以mpMRI为参考比较PET所示前列腺内病灶。

关键影像表现/征象

  • ADT期间前列腺SUVmax较低但未达统计学显著(4.2 vs 6.6,p=0.06)。
  • ADT期间视觉定义的PET DIL显著小于对应mpMRI DIL(p=0.03),ADT前扫描者MRI与视觉定义PET DIL大小无显著差异。
  • 两种分组中阈值法PET产生的DIL均大于视觉法PET。
  • ADT期间3例无视觉可识别PET DIL,ADT前扫描者均有至少一个视觉可识别PET DIL。

诊断标准与关键数值

  • 视觉法与自动阈值法(前列腺SUVmax 60%)PET勾画DIL,与mpMRI比较。
  • 两种PET方法识别MRI定义病灶的敏感度为0.50-0.68,特异度为0.85-0.98。
  • 阈值勾画时高于60%前列腺SUVmax的阈值可能更合适(作者结论)。

临床应用与阅片要点

  • 视觉勾画推量体积时,18F胆碱PET/CT应在ADT前进行(作者结论)。
  • 阈值勾画推量体积时,采用本研究PET/CT扫描方案者,高于60%前列腺SUVmax的阈值可能更合适(作者结论)。
  • 放疗计划中PET联合MRI较单用MRI可显著改变总体推量体积。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Prostate dose painting radiotherapy requires the accurate identification of dominant intraprostatic lesions (DILs) to be used as boost volumes; these can be identified on multiparametric MRI (mpMRI) or choline positron emission tomography (PET)/CT. Planning scans are usually performed after 2-3 months of androgen deprivation therapy (ADT). We examine the effect of ADT on choline tracer uptake and boost volumes identified on choline PET/CT.

METHODS: Fluoroethylcholine (18F choline) PET/CT was performed for dose painting radiotherapy planning in patients with intermediate- to high-risk prostate cancer. Initially, they were performed at planning. Owing to low visual tracer uptake, PET/CT for subsequent patients was performed at staging. We compared these two approaches on intraprostatic lesions obtained on PET using both visual and automatic threshold methods [prostate maximum standardized uptake value (SUVmax) 60%] when compared with mpMRI.

RESULTS: PET/CT was performed during ADT in 11 patients (median duration of 85 days) and before ADT in 29 patients. ADT significantly reduced overall prostate volume by 17%. During ADT, prostate SUVmax was lower although it did not reach statistical significance (4.2 vs 6.6, p = 0.06); three patients had no visually identifiable PET DIL; and visually defined PET DILs were significantly smaller than corresponding mpMRI DILs (p = 0.03). However, all patients scanned before ADT had at least one visually identifiable PET DIL, with no significant size difference between MRI and visually defined PET DILs. In both groups, threshold PET produced larger DILs than visual PET. Both PET methods have moderate sensitivity (0.50-0.68) and high specificity (0.85-0.98) for identifying MRI-defined disease.

CONCLUSION: For visual contouring of boost volumes in prostate dose painting radiotherapy, 18F choline PET/CT should be performed before ADT. For threshold contouring of boost volumes using our PET/CT scanning protocol, threshold levels of above 60% prostate SUVmax may be more suitable. Additional use of PET with MRI for radiotherapy planning can significantly change the overall boost volumes compared with using MRI alone. Advances in knowledge: For prostate dose painting radiotherapy, the additional use of 18F choline PET with MRI can significantly change the overall boost volumes, and PET should be performed before hormone therapy, especially if boost volumes are visually identified.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chan J, Carver A, Brunt JN, et al. Effect of androgen deprivation therapy on intraprostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy. Br J Radiol. 2016. PMID: 27993093. doi:10.1259/bjr.20160818

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。